Pharmacy Landscape

Truveris experts discuss GLP1s (such as Ozempic), the AMP cap in the American Rescue Plan Act, and their impact to pharmacy programs.

Explore the strategies for achieving transparency in pharmacy benefit contracts, a crucial need for employers grappling with rising costs.

The importance of transparency in your pharmacy benefit contract is becoming more prevalent as list prices of specialty drugs increase and plans become more restrictive.

Learn about the role played by your Pharmacy Benefits Manager (PBM) in reducing specialty drug costs and administering your pharmacy benefit.

Alternative funding programs seek to reduce pharmacy spend on specialty drugs by finding alternative sources outside of your pharmacy benefits plan.

Watch as Truveris experts explore the key contract elements and metrics that drive a transparent pharmacy strategy and pricing performance.

In today’s pharmacy environment, many cost containment approaches are losing their effectiveness. These strategies can help employers maximize their pharmacy benefits and reduce costs.

Watch Truveris experts discuss market trends and key considerations for how to develop an effective pharmacy benefits contract strategy in 2023.

By understanding your contract, communicating with your PBM, and working with a partner to craft your pharmacy strategy, you’ll be well prepared for the rise of biosimilar drugs.

Biosimilars are poised to disrupt the drug chain in 2023. What do brokers and plan sponsors need to know?

How can you build more transparency in your pharmacy contract? We lay out five critical strategies to ensure you have control and oversight over your program.

In this Truveris webinar, we join Mployer Advisor to tackle pharmacy benefits 101. What should payers know about PBMs as they plan for 2023?

How can you inject more transparency into your pharmacy plan? Watch the recording of our webinar.

Read what issues the HR leaders at Equinox, Kyndryl, and Phreesia are citing as the biggest benefit challenges this year.

Truveris’ Pharmacy Benefits Glossary of Terms provides important definitions and context to help navigate the pharmacy benefits landscape.

If you work in the pharmacy ecosystem, you’ve probably heard buzz around “biosimilars.” What should you know about this innovative type of medication?

Watch Truveris’ exclusive Human Resources round table, originally recorded on June 8th, 2022.

Plan sponsors are looking for new ways to contain specialty costs. How should they evaluate new copay assistance strategies?

As pharmacy costs increase, what are strategies plan sponsors can take to control specialty pharmacy spend?

Read Sally Welborn’s POV piece on the misaligned incentives at play in the pharmacy benefits ecosystem – and what it means for plan sponsors.

How are copay maximizers and alternative funding impacting plans – and members? Watch our on-demand webinar to learn more.

While a pharmacy benefits contract is a powerful lever for managing spend, it is also very complicated, with variables impacted by market and industry dynamics.

Watch the recording of our webinar and Q&A, led by Clinical Director, Adrienne Trudell (PharmD, BCGP, CPBS), to learn strategies to proactively manage your PBM contract.

340B is increasingly a part of the pharmacy conversation. How should stakeholders react to the program?

Many gene therapy products are soon to be released to the market. What do payers need to know about these highly-expensive specialty drugs?

What is the future of the PBM landscape? Listen to Truveris CEO, Nanette Oddo, opine on the shifts she’s seeing in the pharmacy ecosystem.

Several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?

Understanding the ins and outs of drug formularies is essential to making an informed decision on which PBM to select for your members.

Generic versions of brand name medications are not all the same. Understanding their differences and their implications on MAC pricing is critical for choosing the most cost-effective PBM.

Watch Truveris’ on-demand webinar outlining how Payers can best anticipate and manage new gene therapies.

Looking forward to the future of pharmacy, it’s critical to understand how a specialty drug is defined, how it differs from traditional, non-specialty drugs, and how specialty is impacting employers’ benefit plan designs.  

Watch Truveris’ webinar to learn more about how you can better manage a self-funded specialty pharmacy program.

Pharmacy Benefits Managers, also referred to as PBMs, are the intermediaries between every stakeholder in the pharmacy ecosystem.

Why type of plan sponsor could benefit from carving out their pharmacy plan?

Get up to speed on all the industry-speak and confusing jargon that surrounds the work of PBMs.

The price of drugs on your pharmacy benefits plan can vary dramatically, depending on its type.

In October of 2017, Anthem Inc. announced its launching of IngenioRx, an in-house pharmacy benefits manager (PBM).